** CREDENTIALED MEDIA ONLY **
A briefing on FDA's warning to several medical spas that the cosmetic procedure known as lipodissolve has not been approvedfor use as a fat-removing procedure, and its safety and effectiveness is unknown.
Wednesday, April 7, 2010, 2:00 p.m. EDT
Reporters in the United States can participate by calling 800-857-5159. International callers will need to dial 415-228-4647. The passcode is "FDA."
A replay of the briefing will be available approximately one hour after the event ends until April 14, 2010, at midnight, EDT. To hear the replay, callers in the United States can dial 866-448-4799. International callers can dial 203-369-1173. The passcode is 7050.
CONTACT: Tom Gasparoli, +1-301-796-4737, email@example.com
/PRNewswire-USNewswire -- April 7/
SOURCE U.S. Food and Drug Administration
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All